A seven-year push by Republicans to dismantle the Patient Protection and Affordable Care Act (PPACA) has finally reached a critical phase as Senate GOP leaders unveiled a draft bill that they aim to put to a vote, possibly as early as next week, according to a Reuters report.

Residents in Wisconsin and Indiana who buy insurance on the ACA exchanges will have fewer options next year as Anthem announced yesterday that it is pulling out of those states, the New York Times reports.

The situation is fluid, as it has been since the GOP took over the Senate in January partly because of a promise to repeal and replace Obamacare.

The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee has completed its meeting regarding a supplemental new drug application (sNDA) for the inclusion of data from a pivotal cardiovascular outcomes trial in the labeling for liraglutide (Victoza, Novo Nordisk) injection.

The FDA has given the nod to Mydayis (mixed salts of a single-entity amphetamine product, Shire), a once-daily treatment consisting of three different types of drug-releasing beads for patients 13 years of age and older with attention-deficit/hyperactivity disorder (ADHD). Mydayis is not intended for use in children 12 years of age and younger.

At St. Joseph Hospital in Orange, California, nurse Dawn Nagel is the last line of defense against sepsis, according to an article from Kaiser Health News. Her mission: identify and treat sepsis patients quickly to minimize their risk of death.

The Centers for Medicare and Medicaid Services (CMS) has issued a proposed rule that would make changes in the second year of the Quality Payment Program, as required by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).

FDA Commissioner Scott Gottlieb, MD, has announced in a blog post that the agency plans to hold a public meeting on July 18 to identify ways pharmaceutical companies are using FDA rules—including the standards and procedures related to generic drug approvals—to place obstacles in the way of generic competition.

The Trump administration believes that reining in regulations on pharmaceutical companies is the best way to control the cost of drugs, the New York Times reports.

Major insurers have announced that they’ll not participate in the Obamacare market exchanges next year, and time’s running out for those health plans still on the fence since they must file their intentions and proposed premium rates today.

The FDA has approved delafloxacin (Baxdela, Melinta Therapeutics) for the treatment of adults with acute bacterial skin and skin-structure infections (ABSSSI) caused by susceptible bacteria.

After last month’s terrorist attack in Times Square, doctors and nurses at NYC Health & Hospitals/Bellevue raced to save a high school senior who had sustained serious injuries to her legs, abdomen, and pelvis. The girl was hemorrhaging internally, and transfusions couldn’t keep up with the blood loss. She was about to go into cardiac arrest.

A new study has found that certain factors are linked with a person’s decision to leave the hospital against the advice of his or her care provider. Some of these factors are more pronounced in older versus younger individuals.

Americans with five or more chronic conditions make up 12% of the population but account for 41% of total health care spending, according to a new report from the RAND Corporation. In an article posted on the RealClear Health website, Dr.

Senate Republicans are preparing to vote on repealing the Patient Protection and Affordable Care Act (PPACA) next week, according to an article posted on the Politico website. Senators are expected to begin reviewing the text of the bill as soon as the end of this week.